"We believe that this telemedicine platform is a game-changer for people–no matter where they live–who will be able to get their moles and lesions accurately assessed by a dermatologist without having to endure lengthy wait times to determine if there is cancer present. It brings the advantages of telemedicine to the growing skin cancer problem, while offering the benefits of software as a service (SaaS). We are confident that the deployment of our system will help reduce patient wait times, healthcare costs and mortality rates.”